Literature DB >> 26926000

Intrapartum, postpartum characteristics and early neonatal outcomes of idiopathic polyhydramnios.

Ertugrul Karahanoglu1, Safak Ozdemirci1, Deniz Esinler1, Erdem Fadıloglu1, Seyma Asiltürk1, Taner Kasapoglu1, E Serdar Yalvac1, N Omer Kandemir1.   

Abstract

This paper investigates the effect of idiopathic polyhydramnios on the intrapartum and postpartum characteristics of labour and early neonatal outcomes. In this study, intrapartum and early neonatal outcomes of 207 women with idiopathic polyhydramnios and 336 matched healthy pregnant patients were evaluated. In the case of idiopathic polyhydramnios, the active phase of labour became longer when compared to the control group (5.76 ± 3.56 h vs. 4.38 ± 2.8 h, p: 001). The risk of preterm birth (OR 5.23; 95% CI: 2.04-13.42) and caesarean section (OR 2.26; 95% CI: 1.56-3.28) was higher in women with IP. Patients with IP had a higher rate of transcient tachypnoea of the newborn (TTN), newborn resuscitation, admission to neonatal intensive care unit (NICU), ventilator requirement, newborn jaundice, newborn hypoglycaemia and structural anomalies. IP did not cause any appreciable maternal risk during the intrapartum or postpartum periods. However, neonatal morbidity and post-natal anomaly rates were higher in the case of IP.

Entities:  

Keywords:  Idiopathic polyhydramnios; foetal maternal outcomes; general obstetrics

Mesh:

Year:  2016        PMID: 26926000     DOI: 10.3109/01443615.2016.1148126

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Comparing pregnancy, childbirth, and neonatal outcomes in women with idiopathic polyhydramnios: a prospective cohort study.

Authors:  Raziyeh Vanda; Mahnaz Bazrafkan; Maryam Rouhani; Fatemeh Bazarganipour
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-11       Impact factor: 3.105

2.  A clinical scoring system to predict the need for extensive resuscitation at birth in very low birth weight infants.

Authors:  Juyoung Lee; Jung Hyun Lee
Journal:  BMC Pediatr       Date:  2019-06-14       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.